Navigation Links
New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings
Date:12/7/2009

ATLANTA, Dec. 7 /PRNewswire-FirstCall/ -- Results of two new studies support the use of the intravenous formulation of the antiepileptic drug (AED) Vimpat® for patients requiring add-on therapy in clinical settings where oral AED therapy is temporarily not feasible. These data, which were presented by UCB at the 63rd annual meeting of the American Epilepsy Society in Boston, further clarify the role of intravenous Vimpat in the institutional setting.

One study shows that patients can be transitioned from intravenous Vimpat to the oral formulation, while maintaining steady, therapeutic plasma levels.

"This study shows that intravenous Vimpat is generally well tolerated across a range of doses and infusion durations as a replacement for oral therapy in add-on epilepsy therapy. This will help patients receive Vimpat in clinical settings where administration of an oral epilepsy therapy is not possible, such as emergency rooms or those related to surgery," said study author Gregory Krauss, MD, Department of Neurology, Johns Hopkins Epilepsy Center in Baltimore, MD. "This study helps clinicians understand what to expect when initiating and monitoring intravenous treatment in patients who are Vimpat-naive or who need to substitute oral Vimpat with an intravenous formulation."

A second study provides data on administration of a single intravenous loading dose of Vimpat over 15 minutes, followed by the equivalent daily oral dose administered twice daily.

Vimpat was launched in the U.S. in May 2009 as an add-on therapy for the treatment of partial-onset seizures in people with epilepsy who are 17 years and older. Vimpat has a novel mechanism of action that is different from all currently available AEDs. Vimpat is available as oral tablets and as an intravenous (IV) infusion to allow for consistent treatment in a hospital or emergency setting.

Vimpat can be initiated with either oral
'/>"/>

SOURCE UCB
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Gene Studies of Male-Female Differences Often Flawed
2. Two studies published in the Lancet
3. Study of Studies Finds No Risk to Children From Phthalates in Toys
4. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
5. Studies Prove Exercise Can Heal the Body Mind and Soul
6. Studies Shed New Light on Breast Cancer, Treatment
7. Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Wolters Kluwer , a ... students, announced today that in a survey of nearly ... of the clinical decision support resource improves the quality ... 2014, UpToDate users in more than 170 countries worldwide ... on average. In Germany alone, 95% of all university ...
(Date:5/6/2015)... 06, 2015 Healthcare jobs ... after launching in mid-February. The company connects hospitals, home-health, ... previous experience in the industry. Likewise, job seekers are ... to Kyle Johnson, CTO, unique traffic to the site ... month: "Each new job posting brings targeted, interested candidates ...
(Date:5/6/2015)... Locally owned, Greek olive oil producer and importer, Our Family’s ... one the best Extra Virgin Olive Oils in the world. ... Greece and known as Laconiko , received the ... Oil, which is defined by the competition as “the perfect ... applicants from 25 different countries applying, Laconiko stood out as ...
(Date:5/6/2015)... 06, 2015 Dr. Vito C. Quatela, one ... , recently completed a medical mission trip to Hanoi, Vietnam ... those affected by microtia and other deformities of the face. ... and ended on April 26, Dr. Quatela and his team ... a congenital deformity where the outside of the ear is ...
(Date:5/6/2015)... Los Angeles, California (PRWEB) May 06, 2015 ... has secured its first round of VC funding and ... , The enterprise class embeddable software enables applications ... transform data as it moves between systems and locations. ... the HyperTransfer technology moves files at line speed, independent ...
Breaking Medicine News(10 mins):Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 2Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 4
... New study says that how much we drink may be ... revealed that the gene called DRD2 Taq1A(C32806T) polymorphism and social ... people with a stronger gene of this type will tend ... of this gene. The gene is responsible for enhancing the ...
... study, the drug perindopril used in early treatment of ... onset and progress of left ventricle dysfunction. ... muscular dystrophies that are characterized by muscle enlargement and ... is linked with the X-chromosomes and thus affects male ...
... A research which examined the tobacco byproducts in the ... been fooling // themselves by thinking that they are ... cigarettes. ,No significant difference was found in ... regardless of the type of cigarettes they smoked nor ...
... recent study in the journal Health and Place says that mercury ... of the reasons // of rise in number of autistic children. ... of the power plants that consume coal. According to the researchers, ... into the environment, there is a 61% increase in the rate ...
... E seemed to suggest that supplementing the diet with ... //Recently, a study published In Journal Of American Medical ... may be something very different. ,The researchers ... Prevention Evaluation or HOPE centers between 1993 and 1999, ...
... the apex medical body warns the people of South East ... bird flu virus in the area. It has also ... information to WHO regarding new cases of the disease. The ... closeness in occurrence in time and place is important to ...
Cached Medicine News:
(Date:5/6/2015)... 2015 Woodford Patient Capital ... Trust and the Bill & Melinda Gates Foundation ... a leading monoclonal antibody biopharmaceutical company, announced today ... million to complete a US$90 million Series B ... Woodford Patient Capital Trust plc (LSE:WPCT,"Woodford") and Malin ...
(Date:5/5/2015)... , May 6, 2015 The ... lead the European market in the segment of animal ... alliance ECUPHAR acquires all the assets of Esteve Veterinary ... in the coming weeks. Being both private companies, the ...      (Photo: http://photos.prnewswire.com/prnh/20150506/743274 ) , ...
(Date:5/5/2015)... , May 5, 2015  In line with CBME ... to the community with a charity program to create ... autism. CBME China team is coordinating ... and maternity manufacturers, brand owners and distributors. All donated ... July 2015. Proceeds from the sale will be used ...
Breaking Medicine Technology:Kymab Secures US$90 Million Funding 2Kymab Secures US$90 Million Funding 3Kymab Secures US$90 Million Funding 4ECUPHAR Enters the Spanish and Southern European Markets Through ESTEVE 2CBME China Launches Charity Program to Support Children with Autism 2
... 2011 Researchers from Australia have identified ... factor for Autism Spectrum Disorders.  Pink disease was common in ... illness affecting children between the ages of eighteen months and ... irritability, and progressive loss of speech, symptoms very similar to ...
... CENTENNIAL, Colo., Aug. 9, 2011 AlloSource, a ... soft-tissue allografts for use in surgical procedures around ... with the Alliance for Regenerative Medicine (ARM) and ... membership with both organizations in order to support ...
Cached Medicine Technology:Familial Susceptibility to Mercury is a Risk Factor for Autism 2AlloSource Joins Alliance for Regenerative Medicine, Medical Device Manufacturers Association 2AlloSource Joins Alliance for Regenerative Medicine, Medical Device Manufacturers Association 3
... BALLARD Adult TRACH CARE Double Swivel ... patients. Dual swivels provide flexibility without ... and tactile sleeve for better feel. ... the distance of catheter advance. Offers ...
... KIMBERLY-CLARK BALLARD Adult ... designed for endotracheal intubated ... Features clear T-Piece, lavage/irrigation ... port. Offers multiple tracheostomy ...
... Our soft, flexible whistle tip suction ... kit that includes: One pair of ... 120 ml bottle of sterile saline. ... use with cuffed gloves and catheter ...
... Irri-Cath® catheters help decrease the need ... alternative to fiber-optic bronchoscope for bronchial ... in opportunistic infections., ,All Portex® ... ,The Irri-Cath® suction system ...
Medicine Products: